氟哌啶醇、氯普噻吨和氯丙嗪治疗慢性精神分裂症 - Suppr

Suppr

超能文献

Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia.

作者信息

Serafetinides E A, Willis D, Clark M L

出版信息

J Nerv Ment Dis. 1972 Nov;155(5):366-9. doi: 10.1097/00005053-197211000-00010.

DOI:10.1097/00005053-197211000-00010

PMID:4563078

Abstract

摘要

相似文献

Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia.

J Nerv Ment Dis. 1972 Nov;155(5):366-9. doi: 10.1097/00005053-197211000-00010.

Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.

J Nerv Ment Dis. 1972 Jan;154(1):31-42. doi: 10.1097/00005053-197201000-00005.

Voltage laterality in the EEG of psychiatric patients.

Dis Nerv Syst. 1973 Mar;34(3):190-1.

Clopenthixol: a controlled trial in chronic hospitalized schizophrenic patients.

Br J Psychiatry. 1968 Jul;114(512):833-6. doi: 10.1192/bjp.114.512.833.

Psychological effects of single-dose antipsychotic medication.

Biol Psychiatry. 1973 Dec;7(3):263-7.

Long-term clinical and quantitative EEG effects of clopenthixol in schizophrenics: clinical-neurophysiological correlations.

Int Pharmacopsychiatry. 1973;8(4):193-207. doi: 10.1159/000467993.

A one-year trial of clopenthixol in chronic schizophrenia.

Can Psychiatr Assoc J. 1972 Aug;17(4):321-4. doi: 10.1177/070674377201700409.

Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.

Dis Nerv Syst. 1969 Feb;30(2):Suppl:74-84.

Evaluation of loxapine succinate in chronic schizophrenia.

Dis Nerv Syst. 1972 Dec;33(12):783-91.

A double-blind comparison of sulpiride with chlorpromazine in chronic schizophrenia.

J Clin Pharmacol New Drugs. 1972 May-Jun;12(5):221-9. doi: 10.1002/j.1552-4604.1972.tb00166.x.

引用本文的文献

Major adverse cardiac events with haloperidol: A meta-analysis.

PLoS One. 2025 Jun 25;20(6):e0326804. doi: 10.1371/journal.pone.0326804. eCollection 2025.

Zuclopenthixol dihydrochloride for schizophrenia.

Cochrane Database Syst Rev. 2017 Nov 16;11(11):CD005474. doi: 10.1002/14651858.CD005474.pub2.

Zuclopenthixol versus placebo for schizophrenia.

Cochrane Database Syst Rev. 2015 Dec 1;2015(12):CD010598. doi: 10.1002/14651858.CD010598.pub2.

Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.

Cochrane Database Syst Rev. 2015 Jan 16;1(1):CD009831. doi: 10.1002/14651858.CD009831.pub2.

Chlorpromazine versus placebo for schizophrenia.

Cochrane Database Syst Rev. 2014 Jan 6;2014(1):CD000284. doi: 10.1002/14651858.CD000284.pub3.

Haloperidol versus placebo for schizophrenia.

Cochrane Database Syst Rev. 2013 Nov 15;2013(11):CD003082. doi: 10.1002/14651858.CD003082.pub3.

Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.

Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD000525. doi: 10.1002/14651858.CD000525.pub3.

Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses.

Cochrane Database Syst Rev. 2000;1999(2):CD001164. doi: 10.1002/14651858.CD001164.

Electroencephalogram study of mianserin in depressed patients.

Br J Clin Pharmacol. 1978;5 Suppl 1(Suppl 1):43S-47S.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia.

J Nerv Ment Dis. 1972 Nov;155(5):366-9. doi: 10.1097/00005053-197211000-00010.

Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.

J Nerv Ment Dis. 1972 Jan;154(1):31-42. doi: 10.1097/00005053-197201000-00005.

Voltage laterality in the EEG of psychiatric patients.

Dis Nerv Syst. 1973 Mar;34(3):190-1.

Clopenthixol: a controlled trial in chronic hospitalized schizophrenic patients.

Br J Psychiatry. 1968 Jul;114(512):833-6. doi: 10.1192/bjp.114.512.833.

Psychological effects of single-dose antipsychotic medication.

Biol Psychiatry. 1973 Dec;7(3):263-7.

Long-term clinical and quantitative EEG effects of clopenthixol in schizophrenics: clinical-neurophysiological correlations.

Int Pharmacopsychiatry. 1973;8(4):193-207. doi: 10.1159/000467993.

A one-year trial of clopenthixol in chronic schizophrenia.

Can Psychiatr Assoc J. 1972 Aug;17(4):321-4. doi: 10.1177/070674377201700409.

Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.

Dis Nerv Syst. 1969 Feb;30(2):Suppl:74-84.

Evaluation of loxapine succinate in chronic schizophrenia.

Dis Nerv Syst. 1972 Dec;33(12):783-91.

A double-blind comparison of sulpiride with chlorpromazine in chronic schizophrenia.

J Clin Pharmacol New Drugs. 1972 May-Jun;12(5):221-9. doi: 10.1002/j.1552-4604.1972.tb00166.x.

引用本文的文献

Major adverse cardiac events with haloperidol: A meta-analysis.

PLoS One. 2025 Jun 25;20(6):e0326804. doi: 10.1371/journal.pone.0326804. eCollection 2025.

Zuclopenthixol dihydrochloride for schizophrenia.

Cochrane Database Syst Rev. 2017 Nov 16;11(11):CD005474. doi: 10.1002/14651858.CD005474.pub2.

Zuclopenthixol versus placebo for schizophrenia.

Cochrane Database Syst Rev. 2015 Dec 1;2015(12):CD010598. doi: 10.1002/14651858.CD010598.pub2.

Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.

Cochrane Database Syst Rev. 2015 Jan 16;1(1):CD009831. doi: 10.1002/14651858.CD009831.pub2.

Chlorpromazine versus placebo for schizophrenia.

Cochrane Database Syst Rev. 2014 Jan 6;2014(1):CD000284. doi: 10.1002/14651858.CD000284.pub3.

Haloperidol versus placebo for schizophrenia.

Cochrane Database Syst Rev. 2013 Nov 15;2013(11):CD003082. doi: 10.1002/14651858.CD003082.pub3.

Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.

Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD000525. doi: 10.1002/14651858.CD000525.pub3.

Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses.

Cochrane Database Syst Rev. 2000;1999(2):CD001164. doi: 10.1002/14651858.CD001164.

Electroencephalogram study of mianserin in depressed patients.

Br J Clin Pharmacol. 1978;5 Suppl 1(Suppl 1):43S-47S.